Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Other Non-Current Assets (2016 - 2025)

Assembly Biosciences (ASMB) has 11 years of Other Non-Current Assets data on record, last reported at $312000.0 in Q3 2025.

  • For Q3 2025, Other Non-Current Assets changed 0.0% year-over-year to $312000.0; the TTM value through Sep 2025 reached $312000.0, changed 0.0%, while the annual FY2024 figure was $312000.0, 0.0% changed from the prior year.
  • Other Non-Current Assets reached $312000.0 in Q3 2025 per ASMB's latest filing, roughly flat from $312000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $6.1 million in Q2 2021 and bottomed at $312000.0 in Q4 2023.
  • Average Other Non-Current Assets over 5 years is $1.4 million, with a median of $334000.0 recorded in 2023.
  • Peak YoY movement for Other Non-Current Assets: surged 263.28% in 2021, then plummeted 84.64% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $1.7 million in 2021, then plummeted by 47.8% to $889000.0 in 2022, then crashed by 64.9% to $312000.0 in 2023, then changed by 0.0% to $312000.0 in 2024, then changed by 0.0% to $312000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $312000.0 in Q3 2025, $312000.0 in Q2 2025, and $312000.0 in Q1 2025.